Cipla asks India to revoke Novartis patents on respiratory drug – Reuters
0“Generic drugmaker Cipla Ltd said on Thursday it has asked the Indian government to revoke five patents held by Swiss firm Novartis AG on respiratory drug Onbrez and has launched a cheaper copy to boost access in the local market.
Cipla alleged that Novartis has had patents on the medicine since 2008 but instead of producing it in India has imported a “negligible quantity” from Switzerland, leading to a shortage of supplies in the Indian market.”
From – Reuters